Connect with us

Australia

S&P/ASX 200 falls 0.92% as Australias population growth hits 13½-year low

S&P/ASX 200 (INDEXASX:XJO) halted its two-day run of gains with a 55 point or 0.92% fall to 5,936.5.

While most sectors ended in the red, mining, retailing and communication stocks fell most. Only the utilities sector gained.

Airliners struggled with Qantas (ASX:QAN) down 3.7% as Australias national carrier will cancel most international flight until October.

Major miners declined with Fortescue Metals Group Limited (ASX:FMG) falling 4.24% and Northern Star Resources Ltd (ASX:NST) losing 1.96%.

Population growth rate eases[hhmc]
Australias population increased by 349,833 people during calendar 2019 to 25,522,169 people.

Overall, Australias annual population growth rate eased from 1.43% to 1.39% – the slowest pace in 13½ years.

Western Australia was an exception with mining activity luring more Aussies and overseas migrants to the region, helping the state post its strongest annual population growth rate in 5½ years.

Top gainers[hhmc]
It was another great day for Afterpay (ASX:AP..

S&P/ASX 200 (INDEXASX:XJO) halted its two-day run of gains with a 55 point or 0.92% fall to 5,936.5.

While most sectors ended in the red, mining, retailing and communication stocks fell most. Only the utilities sector gained.

Airliners struggled with Qantas (ASX:QAN) down 3.7% as Australias national carrier will cancel most international flight until October.

Major miners declined with Fortescue Metals Group Limited (ASX:FMG) falling 4.24% and Northern Star Resources Ltd (ASX:NST) losing 1.96%.

Population growth rate eases


Australias population increased by 349,833 people during calendar 2019 to 25,522,169 people.

Overall, Australias annual population growth rate eased from 1.43% to 1.39% – the slowest pace in 13½ years.

Western Australia was an exception with mining activity luring more Aussies and overseas migrants to the region, helping the state post its strongest annual population growth rate in 5½ years.

Top gainers


It was another great day for Afterpay (ASX:APT) hitting record highs for the third day in a row.

Other top gainers on the ASX include 9 Spokes International Ltd (ASX:9SP) (+27.27%), Volt Resources Ltd (ASX:VRC) (+5.26%), Ioneer Ltd (ASX:INR) (+5.00%) and Platina Resources Limited (ASX:PGM) (+4.35%).

Proactive news headlines:

PolarX prepares for Zackly East drilling following strongly supported $3.76 million placement


PolarX Ltd (ASX:PXX) is preparing for a 3,000-metre drilling program at the Zackly East gold-copper skarn within its Alaska Range Project following a strongly supported $3.76 million placement. The company aims to begin the drilling in four weeks using two drill rigs with the program of 15-20 holes expected to take around six to eight weeks.

Macarthur Minerals updating Lake Giles magnetite resource ahead of feasibility study


Macarthur Minerals Limited (ASX:MIO) (CVE:MMS) enjoyed an active start to 2020 with the ongoing development of its flagship Lake Giles Iron Project in Western Australia. The impacts of COVID-19 travel restrictions on operations have been minimal and the goal going forwards is to complete a feasibility study for the project.

Emperor Energy engages AGR to plan and design exploration well in Judith Gas Field offshore Victoria


Emperor Energy Ltd (ASX:EMP) has engaged global well management company AGR to plan and design the Judith 2 Exploration Well in Judith Gas Field in the offshore Gippsland Basin, Victoria. Judith Gas Field, which is 100%-owned by EMP and hosts a P50 unrisked prospective resource of 1.2 Tcf and a 2C contingent resource of 150 Bcf, is strategically positioned to supply high-demand east-coast energy markets in Australia.

Salt Lake Potash CEO and chairman participate in $20 million placement following shareholder approval


Salt Lake Potash Ltd (ASX:SO4) (LON:SO4) (OTCMKTS:WHELF) chief executive officer Tony Swiericzuk and chairman Ian Middlemas have shown their confidence in the company's sulphate of potash (SOP) strategy through participation in a A$20 million placement. After receiving shareholder approval for their participation, on June 17 Swiericzuk acquired 505,833 ordinary shares valued at A$172,000 in a direct interest, increasing the total number held to more than 4.016 million. On the same day, Middlemas acquired 2.25 million shares worth A$765,000 in an indirect interest, increasing the number of securities held after the change to 14.25 million.

Infinity Lithium doubles on key European partnership and investment deal


Infinity Lithium Corporation Ltd (ASX:INF) (FRA:3PM) has further strengthened its European lithium supply strategy by executing binding agreements for a multi-staged funding and added services assistance package with European Union-based innovation initiative KIC InnoEnergy SE. Shares doubled to A$0.14 on the news which sees INFs San José project in Spain become the first lithium project to secure European funding from EIT InnoEnergy, a recently launched platform created by the European Battery Alliance (EBA).

archTIS secures first commercial Defence Industry contract with Northrop Grumman


archTIS Ltd (ASX:AR9) has secured its first Defence Industry commercial contract with Northrop Grumman Corporation (NYSE:NOC) to purchase an initial 50 licences of AR9s Kojensi cloud platform to securely share information for its business development teams. This contract with the global US$53 billion Military System Integrator (MSI) has initial annual recurring reRead More – Source

Continue Reading

Australia

THC Global targets product range expansion and entry into Asia Pacific, Latin America markets

THC Global Group Ltd (ASX:THC) plans to expand its product range and move into new territories in 2021 and beyond as it boosts production at its Southport facility to meet demand from New Zealand and Canadian markets.

The company is targeting to enter the Asia Pacific market in 2021+ with identified potential markets in Thailand, Malaysia, China, South Korea and Japan.

It also sees Latin American and other international opportunities to open with the pharma over-the-counter (OTC) cannabis scale-up.

THC Global operates across the cannabis supply chain, from cultivation, extraction, and direct patient and prescriber support services.

Milestones achieved[hhmc]
THC Global chairman Steven Xu said: “Over the past few months we have achieved several key milestones including launching our Canndeo medicines in Australia, supplying our first prescriptions and signing new production agreements.

“We look forward to building on top of these successes in the coming months and toward supporting ..

THC Global Group Ltd (ASX:THC) plans to expand its product range and move into new territories in 2021 and beyond as it boosts production at its Southport facility to meet demand from New Zealand and Canadian markets.

The company is targeting to enter the Asia Pacific market in 2021+ with identified potential markets in Thailand, Malaysia, China, South Korea and Japan.

It also sees Latin American and other international opportunities to open with the pharma over-the-counter (OTC) cannabis scale-up.

THC Global operates across the cannabis supply chain, from cultivation, extraction, and direct patient and prescriber support services.

Milestones achieved


THC Global chairman Steven Xu said: “Over the past few months we have achieved several key milestones including launching our Canndeo medicines in Australia, supplying our first prescriptions and signing new production agreements.

“We look forward to building on top of these successes in the coming months and toward supporting our target of 6,000 patients using a THC Global produced medicinal cannabis medicine by the end of 2020.”

Export markets


The company has secured agreements to export into Europe, New Zealand and Canada with effect from the third quarter of 2020, with the initial products focusing on CBD medicines range.

Its cannabis medicines are now competitively positioned for direct supply into Canada after receiving Health Canada licensing for Class I, II, III devices and Natural Health Products. Canada has an established market of more than 350,000 registered patients.

It has also inked deals with leading pharmaceutical distributors for New Zealand, as well as to provide prescriber support on cbdinfo.co.nz.

The first order from Medleaf Therapeutics in New Zealand has been received, with an initial supply of 2,250 bottles at $260,000, to be delivered on October 1, 2020.

This order is expected to support up to 800 patients in New Zealand on an ongoing basis.

THC Global is competitively positioned in the New Zealand market due to the requirement from October 2020 for the supply of all future medicines into the country, including future locally sourced medicines, to meet stringent registration requirements.

These include the provision of a six-month expiry date on medicines, which will be a significant time barrier on new market entrants based in New Zealand.

The European supply agreement with Germanys ACA Muller will see its products moving into more than 1,200 pharmacies across the European Union, with the first purchased supply into Europe expected in the fourth quarter this year.

THC Global is completing verification of Good Agricultural and Collecting Practice (GACP) supply for its external suppliers, which is a mandatory requirement for export into Europe.

The companys manufacturing facility is Good Manufacturing Practices (GMP) licensed by the Therapeutic Goods Administration in Australia and has reciprocal recognition across Europe in meeting EU-GMP requirements.

Domestic boost with rescheduling of CBD medicines


The company is also preparing for the rescheduling of CBD medicines in Australia, which is expected in the first quarter of 2021 and is readying products for the required specific Schedule 3 registration throughout 2020.

The Pharma Over-The-Counter (OTC) CBD medicines market will open supply to Australians via pharmacies without the need for a prescription.

THC believes it is the best placed to dominate this market with a global supply chain supplemented with large-scale, low-cost cultivation options and Australias largest capacity dedicated cannabis medicine manufacturing facility.

The value of the future Pharma OTC CBD medicines market has been projected to potentially exceed $200 million per year.

Spike in patient enquiries at Tetra Health


In June, Tetra Health, which THC Global acquired this year, received a 30% increase in patient inquiries and this trend is expected to continue.

In line with this, THC Global is expanding Tetra Healths clinical staff to ensure it can manage a continued increase in patients whilst ensuring a high level of patient support and care.

Tetra Health is a product-agnostic clinic, focused on medicinal cannabis prescribing, ongoing patient care and collecting real-world evidence on medicinal cannabis medicines.

It offers patients and prescribers a broad range of medicinal cannabis medicines, including THC Globals Canndeo medicines and medicines produced by THC Global uRead More – Source

Continue Reading

Australia

Peninsula Energy confirms strong director support for $40.3 million entitlement offer

Peninsula Energy Ltd (ASX:PEN) directors have acquired shares in the company via their participation in the recently completed $40.3 million entitlement offer.

Managing Director Wayne Heili acquired 1,290,476 shares, finance director/CFO David Coyne acquired 280,000 shares, non-executive chairman John Harrison added 37,800 shares and non-executive director Mark Wheatley bought 232,281 shares.

The newly acquired shares of Heili and Coyne also includes the vesting of previously approved Restricted Share Units and unlisted options to them.

Uranium production re-start strategy[hhmc]
The entitlement offer has allowed Peninsula to repay its existing term debt in full (principal amount of US$16.821 million (~$24.7 million) leaving the company cashed-up andRead More – Source

[contf]
[contfnew]

Proactiveinvestors
[contfnewc]
[contfnewc]

Peninsula Energy Ltd (ASX:PEN) directors have acquired shares in the company via their participation in the recently completed $40.3 million entitlement offer.

Managing Director Wayne Heili acquired 1,290,476 shares, finance director/CFO David Coyne acquired 280,000 shares, non-executive chairman John Harrison added 37,800 shares and non-executive director Mark Wheatley bought 232,281 shares.

The newly acquired shares of Heili and Coyne also includes the vesting of previously approved Restricted Share Units and unlisted options to them.

Uranium production re-start strategy


The entitlement offer has allowed Peninsula to repay its existing term debt in full (principal amount of US$16.821 million (~$24.7 million) leaving the company cashed-up andRead More – Source

Continue Reading

Australia

Infinity Lithium releases 3D video showcasing sustainable San José Lithium Project

Infinity Lithium Ltd (ASX:INF) has released a 3D video showing reproductions of what the sustainable San Jose Valdeflórez Lithium Project in Cáceres, Spain, will look like.

The video, which lasts for about two minutes, showcases how the project is designed to guarantee the protection of the citys ecosystem with the responsible use of water and health protection initiatives.

This digital recreation shows details of the mining area, the industrial plant and the tailings as well as the continuous rehabilitation of the site.

[embedded content]

Europe's second-largest lithium deposit[hhmc]
San José Valdeflórez, which is the second-largest lithium deposit in the European Union, is set to put Cáceres on the map of the electric vehicle (EV) sector.

INF is working to develop a sustainable project that offers opportunities for the strategic development of a fully integrated supply chain for EVs in Europe

The video states Cáceres has the opportunity to set an example globally with a te..

Infinity Lithium Ltd (ASX:INF) has released a 3D video showing reproductions of what the sustainable San Jose Valdeflórez Lithium Project in Cáceres, Spain, will look like.

The video, which lasts for about two minutes, showcases how the project is designed to guarantee the protection of the citys ecosystem with the responsible use of water and health protection initiatives.

This digital recreation shows details of the mining area, the industrial plant and the tailings as well as the continuous rehabilitation of the site.

Europe's second-largest lithium deposit


San José Valdeflórez, which is the second-largest lithium deposit in the European Union, is set to put Cáceres on the map of the electric vehicle (EV) sector.

INF is working to develop a sustainable project that offers opportunities for the strategic development of a fully integrated supply chain for EVs in Europe

The video states Cáceres has the opportunity to set an example globally with a technology that is already changing the world – electric mobility.

Lithium supply strategy


Infinity recently strengthened its European lithium supply strategy by executing binding agreementRead More – Source

Continue Reading

Trending